Main Session
Sep
28
SS 16 - Early Stage and Locally Advanced NSCLC
179 - Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT): Long-Term Outcomes
Presenter(s)
Caroline Oska, MD - Montefiore Einstein Comprehensive Cancer Center, Bronx, NY